DRIO.NASDAQDariohealth CORP

Form 4: DarioHealth Corp. Executive Steven Nelson Buys 10,000 Shares

Sentiment:

SEC Form 4 Filing


Steven Nelson, Chief Commercial Officer of DarioHealth Corp., recently purchased 10,000 shares of the company's common stock in two separate transactions.

Summary

  • Steven Nelson, the Chief Commercial Officer of DarioHealth Corp., has reported purchasing shares of the company's common stock.
  • On August 19, 2024, Nelson acquired 5,000 shares at a price of $0.9197 per share.
  • Following this, on August 20, 2024, Nelson purchased an additional 5,000 shares at $0.9369 per share.
  • These transactions bring Nelson's total direct ownership to 10,000 shares of DarioHealth Corp. common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. An executive buying shares is generally a good sign, but the purchase is relatively small and doesn't provide a strong signal.

Positives

  • An executive's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored by investors as it can provide insights into management's perspective on the company's valuation and future performance. It's a common practice and is regulated to prevent illegal insider trading.

Stakeholder Impact

  • Shareholders may view the executive's stock purchase as a positive signal.

Key Dates

DateDescription
08/19/2024Steven Nelson purchased 5,000 shares of DarioHealth Corp. common stock at $0.9197 per share.
08/20/2024Steven Nelson purchased 5,000 shares of DarioHealth Corp. common stock at $0.9369 per share.
08/20/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.